GlassScriptPhysician profile
Scott Gavin Ewing
NPI 1528485190
$68,217.19
in general payments reported to CMS, 2019-2025
10 companies · $36K in 2025
The $36K reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.10 · 2021: $21.87 · 2022: $957 · 2023: $273 · 2024: $31K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $66K · Food and Beverage: $419 · Gift: $270 · Entertainment: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $66,385.42 |
| Food and Beverage | $418.99 |
| Gift | $270.00 |
| Entertainment | $136.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neocis INC. | $66,385.42 | 2024-2025 | |
| Straumann USA LLC | $1,138.06 | 2022-2025 | |
| A-Dec, INC. | $270.00 | 2025 | |
| Biohorizons Implant Systems INC. | $157.31 | 2022 | |
| Keystone Dental INC. | $136.50 | 2023-2024 | |
| Solventum Corporation | $66.12 | 2024 | 3m Filtek, 3m Scotchbond, 3m Relyx |
| Neoss, INC. | $21.87 | 2021 | |
| Philips North America LLC | $15.01 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $14.81 | 2023 | |
| Dentsply Sirona INC | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Ewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.